Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Mar 18, 2013 |
EVP, Chief Development Officer
|
EVP, Chief Development Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | -- | 28,950 |
Feb 27, 2013 |
EVP, Chief Development Officer
|
EVP, Chief Development Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12,214 | -- | 83,548 |
Feb 21, 2013 |
EVP, Chief Development Officer
|
EVP, Chief Development Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 24,154 | -- | 71,334 |
Mar 28, 2012 |
EVP, Chief Development Officer
|
EVP, Chief Development Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 12,000 | -- | 43,607 |
Mar 16, 2012 |
EVP, Chief Development Officer
|
EVP, Chief Development Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 57,047 | -- | 57,047 |
Feb 27, 2012 |
EVP, Chief Development Officer
|
EVP, Chief Development Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 18,717 | -- | 52,131 |
Feb 25, 2011 |
EVP, Chief Development Officer
|
EVP, Chief Development Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,674 | -- | 33,414 |
Feb 25, 2011 |
EVP, Chief Development Officer
|
EVP, Chief Development Officer | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12,916 | -- | 37,656 |
Feb 23, 2011 |
EVP, Chief Development Officer
|
EVP, Chief Development Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 43,950 | -- | 43,950 |
Nov 10, 2010 |
EVP, Chief Development Officer
|
EVP, Chief Development Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 12,000 | -- | 55,607 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.